Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-02

FDA Approved: LUMIFY REDNESS RELIEVER EYE DROPS — Supplemental Application (Bausch & Lomb Incorporated)

View source ↗

Summary

The FDA approved a supplemental application for Lumify redness-relief eye drops (brimonidine tartrate) from Bausch & Lomb, updating the labeling to reflect the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LUMIFY REDNESS RELIEVER EYE DROPS (Brimonidine tartrate)

Snippet

SUPPL AP for LUMIFY REDNESS RELIEVER EYE DROPS (BRIMONIDINE TARTRATE)